Bristol Myers Squibb SWOT Analysis
Here is a detailed SWOT analysis of Bristol Myers Squibb covering strengths, weaknesses, opportunities and threats.
Bristol Myers Squibb Strengths
- Deliver new medicines regularly
- Provide free medications to qualifying patients with financial problems in the U.S.
- Employ 44000 people all over world, strong global footprint
- Corporate strategy with the acquisition of many other companies
- String of new technologies, alliances has strengthened the brand
- Co-development and co-commercialization agreements with companies have boosted image
Above are the strengths in the SWOT Analysis of Bristol Myers Squibb. The strengths of Bristol Myers Squibb looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Bristol Myers Squibb Weaknesses
- Strong dependence on working with third parties to improve and enhance abilities
- Substantial drop in sales for two key drugs: Plavix, a blood thinner, and Pravachol, a cholesterol-lowering drug.
- Company layoffs and post retirement plans may affect employee relations.
These were the weaknesses in the Bristol Myers Squibb SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Bristol Myers Squibb Opportunities
- Security technologies to make packaging and products less vulnerable to counterfeiting and to secure their movement within the supply chain
- An integrated team addresses counterfeiting, product tampering, theft and diversion issues
- Expand access to its products through strategic acquisitions & partnerships.
Above we covered the opportunities in Bristol Myers Squibb SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Read more about Bristol Myers Squibb
Bristol Myers Squibb Threats
- The company acquires biotech companies, technology and expertise and hence a threat to its culture is infused ever more deeply.
- Counterfeit drugs and product tampering, theft or diversion represent a threat
- Pricing pressures
- Global economic slowdown
The threats in the SWOT Analysis of Bristol Myers Squibb are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Bristol Myers Squibb SWOT analysis.
Read Similar SWOT analysis
About Bristol Myers Squibb
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Bristol Myers Squibb Overview | |
|---|---|
| Parent Company |
Bristol Myers Squibb |
| Category |
Biopharmaceuticals |
| Sector | |
| Tagline/ Slogan |
Together we can prevail |
| USP |
Bristol-Myers Squibb is a global BioPharma company focused to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. |
| Bristol Myers Squibb STP | |
| Segmentation |
Diseases such as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders |
| Target Market |
Healthcare professionals, doctors, pharmacists |
| Positioning |
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. |
Browse marketing analysis of more brands and companies similar to Bristol Myers Squibb. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
